Boston Scientific Corp's Fiscal Year is From January To December.
The item "Price-To-Cashflow-Ratio" stands at 21.97 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Boston Scientific Corp's third quarter, the item "Price To Cashflow Ratio" stands at 21.97. This represents a decrease of -39.38 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -47.06 percent compared to the value the year prior.
The 1 year change in percent is -47.06.
The 3 year change in percent is -55.23.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Price To Cashflow Ratio | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Price To Cashflow Ratio | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Price To Cashflow Ratio | 172,241,486,586.05 |
![]() | Danaher Corporation - Price To Cashflow Ratio | 162,006,663,168.00 |
![]() | Stryker Corporation - Price To Cashflow Ratio | 139,209,850,880.00 |